2011•LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)Open access

Preparation and characterization of spherical agglomerates of piroxicam

Mudit Dixit, Parthasarathi Keshavarao Kulkarni

Open full text 3 citations

Abstract

The purpose of the present study was to prepare spherical agglomerates (SA) of piroxicam by solvent change method. Crystallization medium used for spherical agglomerates of piroxicam consisted of DMF:water and chloroform. The presence of solvents residual in SA was determined by gas chromatography and were particles were characterized by DSC, FT-IR, XRD and SEM. The respective solubility study and dissolution behavior studies were carried out. The samples were stored in stability chamber to investigate their physical stabilities. Solvents residuals in SA were found to be within the limits and exhibited decreased crystallinity of piroxicam in SA than pure piroxicam. The solubility and dissolution of the spherical agglomerates was improved compared with pure piroxicam and recrystallized sample. In stability test, the release profile of the spherical agglomeration was almost unchanged as compared with the freshly prepared spherical agglomeration stored at 20 °C and 45 % relative humidity for 90 days. Hence this technique can be used to obtain modified drug raw material for formulation of tablets of piroxicam by direct compression with directly compressible tablet excipients.

Open-access reader

About this research paper

What this paper is about

The purpose of the present study was to prepare spherical agglomerates (SA) of piroxicam by solvent change method. Crystallization medium used for spherical agglomerates of piroxicam consisted of DMF:water and chloroform. The presence of solvents residual in SA was determined by gas chromatography and were particles were characterized by DSC, FT-IR, XRD and SEM. The respective solubility study and dissolution behavior studies were carried out. The samples were stored in stability chamber to investigate their physical stabilities. Solvents residuals in SA were found to be within the limits and exhibited decreased crystallinity of piroxicam in SA than pure piroxicam. The solubility and dissolution of the spherical agglomerates was improved compared with pure piroxicam and recrystallized sample. In stability test, the release profile of the spherical agglomeration was almost unchanged as compared with the freshly prepared spherical agglomeration stored at 20 °C and 45 % relative humidity for 90 days. Hence this technique can be used to obtain modified drug raw material for formulation of tablets of piroxicam by direct compression with directly compressible tablet excipients.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The purpose of the present study was to prepare spherical agglomerates (SA) of piroxicam by solvent change method. Crystallization medium used for spherical agglomerates of piroxicam consisted of DMF:water and chloroform. The presence of solvents residual in SA was determined by gas chromatography and were particles were characterized by DSC, FT-IR, XRD and SEM. The respective solubility study and dissolution behavior studies were carried out. The samples were stored in stability chamber to investigate their physical stabilities. Solvents residuals in SA were found to be within the limits and exhibited decreased crystallinity of piroxicam in SA than pure piroxicam. The solubility and dissolution of the spherical agglomerates was improved compared with pure piroxicam and recrystallized sample. In stability test, the release profile of the spherical agglomeration was almost unchanged as compared with the freshly prepared spherical agglomeration stored at 20 °C and 45 % relative humidity for 90 days. Hence this technique can be used to obtain modified drug raw material for formulation of tablets of piroxicam by direct compression with directly compressible tablet excipients.

Key concepts: Tenoxicam, Piroxicam, Agglomerate, Dissolution, Crystallinity, Solubility, Chromatography, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Preparation and characterization of spherical agglomerates of piroxicam — Research Paper | ScholarLens